$5.52
3.66% yesterday
Nasdaq, Nov 26, 10:00 pm CET
ISIN
US35803L1089
Symbol
KRRO

Frequency Therapeutics Inc Stock price

$5.52
-34.06 86.05% 1M
-8.28 60.00% 6M
-32.55 85.50% YTD
-47.73 89.63% 1Y
-99.48 94.74% 3Y
-1,296.98 99.58% 5Y
-679.48 99.19% 10Y
-679.48 99.19% 20Y
Nasdaq, Closing price Wed, Nov 26 2025
-0.21 3.66%
ISIN
US35803L1089
Symbol
KRRO
Industry

Key metrics

Basic
Market capitalization
$52.0m
Enterprise Value
$-44.4m
Net debt
positive
Cash
$96.4m
Shares outstanding
9.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
8.3 | 10.6
EV/Sales
negative | negative
EV/FCF
0.6
P/B
0.5
Financial Health
Equity Ratio
70.9%
Return on Equity
-52.1%
ROCE
-60.4%
ROIC
-133.2%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$6.3m | $4.9m
EBITDA
$-94.0m | -
EBIT
$-98.6m | $-105.0m
Net Income
$-91.4m | $-97.2m
Free Cash Flow
$-73.9m
Growth (TTM | estimate)
Revenue
- | 117.0%
EBITDA
0.2% | -
EBIT
-0.8% | -14.2%
Net Income
0.9% | -16.3%
Free Cash Flow
26.5%
Margin (TTM | estimate)
Gross
-
EBITDA
-1,496.3% | -
EBIT
-1,569.1%
Net
-1,454.5% | -1,972.4%
Free Cash Flow
-1,175.9%
More
EPS
$-9.7
FCF per Share
$-7.9
Short interest
20.2%
Employees
104
Rev per Employee
$20.0k
Show more

Is Frequency Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,049 stocks worldwide.

Frequency Therapeutics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Frequency Therapeutics Inc forecast:

14x Buy
93%
1x Hold
7%

Analyst Opinions

15 Analysts have issued a Frequency Therapeutics Inc forecast:

Buy
93%
Hold
7%

Financial data from Frequency Therapeutics Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
6.28 6.28
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 31 31
21% 21%
496%
- Research and Development Expense 74 74
2% 2%
1,174%
-94 -94
0% 0%
-1,496%
- Depreciation and Amortization 4.57 4.57
27% 27%
73%
EBIT (Operating Income) EBIT -99 -99
1% 1%
-1,569%
Net Profit -91 -91
1% 1%
-1,455%

In millions USD.

Don't miss a Thing! We will send you all news about Frequency Therapeutics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Frequency Therapeutics Inc Stock News

Negative
Investors Business Daily
14 days ago
Korro Bio stock plummeted Thursday after its RNA-editing drug failed to pass muster in patients with a rare lung and liver disease.
Negative
Market Watch
14 days ago
Korro is the latest to rethink its ties with the Danish pharma company.
Neutral
GlobeNewsWire
15 days ago
CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- — KRRO-110 produced functional protein in Alpha-1 Antitrypsin Deficiency (AATD) patients     — KRRO-110 did not reach projected levels of functional protein following a single administration      — Pivoting to GalNAc delivery for patients with AATD; development candidate nomination expected in the first half of 2026     — Nominated KRRO-121, d...
More Frequency Therapeutics Inc News

Company Profile

Frequency Therapeutics, Inc. engages in the development of small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Its product pipeline include Sensorineural hearing loss (FX-322), and Multiple Sclerosis. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean on November 13, 2014 and is headquartered in Woburn, MA.

Head office United States
CEO Ram Aiyar
Employees 104
Founded 2018
Website www.korrobio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today